SOFFAUVO Trademark
Trademark Overview
On Wednesday, April 15, 2026, a trademark application was filed for SOFFAUVO with the United States Patent and Trademark Office. The USPTO has given the SOFFAUVO trademark a serial number of 99764767. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, May 21, 2026. This trademark is owned by Eli Lilly and Company. The SOFFAUVO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorder, alopecia, Alzheimer’s disease, asthma, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular disease, central nervous system diseases and disorders, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, psoriasis, psoriatic arthritis, retinal disease, rheumatoid arthritis, ulcerative colitis, vascular diseases and vision l...
General Information
| Serial Number | 99764767 |
| Word Mark | SOFFAUVO |
| Filing Date | Wednesday, April 15, 2026 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, May 21, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 9, 2026 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorder, alopecia, Alzheimer’s disease, asthma, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular disease, central nervous system diseases and disorders, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, psoriasis, psoriatic arthritis, retinal disease, rheumatoid arthritis, ulcerative colitis, vascular diseases and vision loss; pharmaceutical preparations for weight management. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 15, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Eli Lilly and Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285
US |
Trademark Events
| Event Date | Event Description |
| Wednesday, April 15, 2026 | NEW APPLICATION ENTERED |
| Wednesday, April 15, 2026 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, April 15, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, May 12, 2026 | ASSIGNED TO EXAMINER |
| Thursday, May 14, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 3, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
